SCHEMBL30737388

SCHEMBL30737388

COCCOc1cccc(Oc2ccc(C(=O)Cl)cn2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 2/20 0.45
CHEK1 O14757 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
BRCA1 P38398 1/20 0.44
HBB P68871 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
MAPK1 P28482 3/20 0.43
GRN P28799 2/20 0.42
SORT1 Q99523 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 1/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
RAB9A P51151 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737233 0.89 MAPT (0.49) CHEK2CHEK1ALDH1A1MEN1KMT2A
SCHEMBL31646216 0.88 MAPT (0.50) CHEK2CHEK1ALDH1A1MEN1KMT2A
SCHEMBL4253237 0.86 MEN1 (0.59) ALDH1A1MEN1KMT2AKDM4EBRCA1
SCHEMBL30737317 0.79 F10 (0.52) ALDH1A1MEN1KMT2AHRH3MAPK1
SCHEMBL9565397 0.79 KMT2A (0.54) CHEK2CHEK1ALDH1A1MEN1KMT2A
SCHEMBL30785561 0.79 KMT2A (0.54) CHEK2CHEK1ALDH1A1MEN1KMT2A
SCHEMBL4253033 0.78 HRH3 (0.54) ALDH1A1KMT2AHRH3L3MBTL1RAB9A
Hydrochloric Acid SCHEMBL4254469 0.78 OPRM1 (0.45) ALDH1A1HRH3HTTNPSR1
SCHEMBL3645651 0.77 HRH3 (0.53) HRH3GRNSORT1CTSA
SCHEMBL30737284 0.77 HDAC3 (0.46) MEN1KMT2AHRH3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 CHEK2 3803/4885CHEK1 4291/4885ALDH1A1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.